CVS vs SPY: CVS Health Corporation vs SPDR S&P 500 ETF Trust Historical Returns & Investment Comparison

This CVS vs SPY comparison analyzes the historical stock performance of CVS Health Corporation and SPDR S&P 500 ETF Trust side-by-side. Using real, adjusted market data, this tool shows how identical investments in both stocks would have performed over time—highlighting differences in returns, volatility, and consistency across market cycles.

Use the interactive calculator below to adjust the investment amount and time period, visualizing how CVS Health Corporation and SPDR S&P 500 ETF Trust have historically performed against each other.

Compare Stock Performance

Select two stocks and an investment amount to see how they compare over time.

Compare any two stocks to see which performed better historically

Performance Summary

$10,000 invested from 1986 to 2025 (40 years)

Head-to-Head Record

19
CVS Wins
0
Ties
14
SPY Wins

Over the 33-year comparison period, CVS Health Corporation outperformed SPDR S&P 500 ETF Trust in 19 years, while SPDR S&P 500 ETF Trust outperformed CVS Health Corporation in 14 years.

CVS - CVS Health Corporation

Average Annual Return:+13.31%
Best Year:+85.62% (2025)
Worst Year:-47.97% (2001)
Win Rate:62.5% (25/40 years)
Total Value:$317,973.27
Total Gain:+$307,973.27 (+3079.73%)

SPY - SPDR S&P 500 ETF Trust

Average Annual Return:+11.71%
Best Year:+37.39% (1995)
Worst Year:-36.24% (2008)
Win Rate:81.8% (27/33 years)
Total Value:$250,597.02
Total Gain:+$240,597.02 (+2405.97%)

Overall Winner: CVS with an average annual return of 13.31% (vs 11.71% for SPY)

Understanding CVS vs SPY Performance

When comparing CVS Health Corporation and SPDR S&P 500 ETF Trust, investors should consider multiple factors beyond just total returns. Volatility, consistency of growth, dividend payments, and sector-specific risks all play crucial roles in determining which stock might be better suited for your investment strategy and risk tolerance.

Historical performance data shows how each stock responded to market downturns, economic expansions, and company-specific events. While past performance doesn't guarantee future results, understanding these patterns can help inform investment decisions and portfolio allocation strategies.

Cumulative Growth Comparison

A $10,000 investment in CVS Health Corporation grew to $317,973, compared to $250,597 for SPDR S&P 500 ETF Trust over the same period.

Year-by-Year Comparison

YearCVS ReturnCVS CumulativeSPY ReturnSPY CumulativeDifferenceWinner
1986 (Start)-$10,000.00-$10,000.00-Initial Investment
1987+9.02%$10,901.92---Tie
1988-0.93%$10,800.56---Tie
1989+42.22%$15,360.27---Tie
1990+24.06%$19,056.09---Tie
1991-4.15%$18,264.90---Tie
1992+10.61%$20,202.95---Tie
1993+25.26%$25,306.69---Tie
1994-21.74%$19,805.91+8.71%$10,870.91-30.45% (SPY)SPY
1995-20.41%$15,763.04+0.67%$10,943.47-21.08% (SPY)SPY
1996+2.46%$16,150.62+37.39%$15,035.16-34.93% (SPY)SPY
1997+51.44%$24,458.63+21.20%$18,223.19+30.24% (CVS)CVS
1998+63.30%$39,942.05+33.14%$24,261.81+30.17% (CVS)CVS
1999+73.71%$69,382.88+28.03%$31,063.11+45.68% (CVS)CVS
2000-24.64%$52,285.86+20.66%$37,482.18-45.31% (SPY)SPY
2001+59.40%$83,343.52-8.85%$34,165.23+68.25% (CVS)CVS
2002-47.97%$43,366.77-10.13%$30,703.75-37.83% (SPY)SPY
2003-14.96%$36,878.88-22.42%$23,820.14+7.46% (CVS)CVS
2004+43.36%$52,869.47+24.18%$29,580.86+19.18% (CVS)CVS
2005+26.84%$67,061.18+10.75%$32,760.13+16.10% (CVS)CVS
2006+18.07%$79,180.63+5.32%$34,504.59+12.75% (CVS)CVS
2007+17.92%$93,370.60+13.84%$39,281.03+4.08% (CVS)CVS
2008+29.72%$121,119.56+5.33%$41,375.53+24.39% (CVS)CVS
2009-26.42%$89,114.87-36.24%$26,382.38+9.81% (CVS)CVS
2010+10.71%$98,655.49+22.65%$32,359.23-11.95% (SPY)SPY
2011+6.57%$105,136.30+13.14%$36,610.39-6.57% (SPY)SPY
2012+17.99%$124,051.04+0.85%$36,922.44+17.14% (CVS)CVS
2013+18.14%$146,551.61+14.17%$42,154.69+3.97% (CVS)CVS
2014+46.36%$214,487.53+29.00%$54,380.19+17.35% (CVS)CVS
2015+38.83%$297,780.90+14.56%$62,298.86+24.27% (CVS)CVS
2016+4.21%$310,319.13+1.29%$63,101.60+2.92% (CVS)CVS
2017-16.71%$258,451.00+13.59%$71,674.43-30.30% (SPY)SPY
2018-7.44%$239,218.88+20.78%$86,569.38-28.22% (SPY)SPY
2019-8.33%$219,301.38-5.25%$82,026.91-3.08% (SPY)SPY
2020+17.15%$256,917.75+31.09%$107,527.02-13.93% (SPY)SPY
2021-4.97%$244,136.72+17.24%$126,059.55-22.21% (SPY)SPY
2022+51.13%$368,962.87+30.51%$164,514.60+20.62% (CVS)CVS
2023-8.51%$337,554.04-18.65%$133,838.54+10.13% (CVS)CVS
2024-12.27%$296,135.85+26.71%$169,585.78-38.98% (SPY)SPY
2025-42.15%$171,300.19+25.59%$212,981.61-67.74% (SPY)SPY
2026+85.62%$317,973.27+17.66%$250,597.02+67.96% (CVS)CVS

Annual returns include dividends and stock splits. Cumulative values show growth of $10,000 invested from the first year. Positive difference means CVS outperformed SPY that year.

Company Profiles

1

CVS Health Corporation

CVS

CVS Health Corporation is an American multinational healthcare company that has evolved from a retail pharmacy chain into a diversified healthcare provider. It offers integrated health plans and services, including medical, dental, disability, life, and accident insurance, as well as pharmacy services and healthcare solutions.

Key Innovations

  • Pioneered the concept of in-store health clinics (MinuteClinic), making healthcare more accessible.
  • Successfully integrated health insurance (Aetna) with pharmacy services and other healthcare solutions, creating a vertically integrated healthcare company.

Business Segments

  • Health Care Benefits
    Provides a full range of traditional, voluntary, and consumer-directed health insurance products and related services through Aetna.
  • Pharmacy Services
    Provides pharmacy benefit management (PBM) services, mail order pharmacy, specialty pharmacy, and retail long-term care pharmacy services through CVS Caremark.
  • Retail/Long-Term Care
    Operates retail pharmacies (CVS Pharmacy) andMinuteClinic walk-in medical clinics, offering prescription and over-the-counter drugs, as well as health and wellness products.
2

SPDR S&P 500 ETF Trust

SPY

SPY is the first exchange-traded fund (ETF) listed in the US. It is designed to track the S&P 500 Index, which measures the performance of the large-cap segment of the US equity market.

Key Innovations

  • First US-listed ETF

Business Segments

  • ETF
    Passive investment vehicle tracking the S&P 500.

How This Comparison Works

Our stock comparison tool uses adjusted closing prices to calculate year-by-year returns for both stocks. This ensures an apples-to-apples comparison that accounts for:

  • Dividends: All dividend payments are reinvested
  • Stock splits: Historical prices are adjusted for all splits
  • Head-to-head record: Shows which stock outperformed each year
  • Statistical analysis: Average returns, best/worst years, and win rates

Share This Comparison

Important Disclaimer

This comparison tool is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Past performance is not indicative of future results. Historical returns include dividends and stock splits but do not account for taxes, fees, inflation, or individual circumstances. Stock market investments carry risk, including the potential loss of principal. Always consult with a qualified financial advisor before making investment decisions. The data presented is based on historical market data and may contain inaccuracies or delays.